A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate
- PMID: 26997774
- PMCID: PMC4741129
- DOI: 10.5005/jp-journals-10008-1130
A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate
Abstract
Objective: To evaluate by survey the comfort upon instillation of timolol hemihydrate compared to timolol maleate with potassium sorbate.
Design: A prospective, multicenter, observational, non-interventional study.
Participants: One hundred and three patients of open-angle glaucoma or ocular hypertension who were ≥21 years old and were currently prescribed timolol hemihydrate (once or twice daily) or timolol maleate with potassium sorbate once daily as monotherapy or as a part of two-drug therapy.
Materials and methods: Study was performed at seven clinical sites in the United States. Patients were surveyed on comfort upon instillation of timolol hemihydrate compared to timolol maleate with potassium sorbate.
Results: A difference between timolol hemihydrate and timolol maleate with potassium sorbate for questions 1 (burning/stinging on instillation, p < 0.001) and 4 (tearing on instillation, p = 0.024) was noted. There were no differences between treatment groups for any other question (p > 0.05).
Conclusion: This survey suggests that timolol hemihydrate is associated with less stinging/burning and tearing than timolol maleate with potassium sorbate. How to cite this article: Stewart WC, Oehler JC, Choplin NT, Markoff JI, Moster MR, Ichhpujani P, Nelson LA. A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate. J Current Glau Prac 2013;7(1):11-16.
Keywords: Betimol; Comfort; Glaucoma; Istalol; Timolol hemihydrate; Timolol maleate with potassium sorbate..
Conflict of interest statement
References
-
- DuBiner HB, Hill R, Kaufman H, Keates EU, Zimmerman TJ, Mandell AI, Mundorf TK, Bahr RL, Schwartz LW, Towey AW. Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma. Am J Ophthalmol. 1996 May;121(5):522–528. - PubMed
-
- Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocul Pharmacol Ther. 1998 Apr;14(2):129–135. - PubMed
-
- Stewart WC, Day DG, Sharpe ED, Dubiner HB, Holmes KT, Stewart JA. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost. Am J Ophthalmol. 1999 Dec;128(6):692–696. - PubMed
-
- Mundorf TK, Ogawa T, Inui N, Naka H, Novack GD, Crockett RS. Timolol LA: a double-masked, active-controlled, randomized, crossover, comfort, ocular safety and systemic bioavaila-bility study in healthy volunteers. Curr Med Res Opin. 2005 Mar;21(3):369–374. - PubMed
-
- Mundorf TK, Ogawa T, Naka H, Novack GD, Crockett RS. A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension. Clin Ther. 2004 Apr;26(4):541–551. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials